Mycoplasma arthritidis, M. hominis, and M. arginini were tested for their ability to induce a cytotoxic response from normal CBA mouse lymphocytes against 5"Cr-labeled allogeneic and syngeneic target cells. In most cases, the mycoplasmas alone were not toxic for the target cells. Furthermore, the mycoplasmas did not result in decreased lymphocyte viability but, in fact, contributed to enhanced lymphocyte survival. In the absence of normal CBA lymphocytes, mycoplasmas alone did not induce a significant amount of cell damage in either the allogeneic or the syngeneic target cells. Strains of M. arthritidis and M. hominis, when added to the lymphocyte-target cell mixtures, induced statistically significant increases in 51Cr release from both target cell types at each assay period after 6 h. The release of 5"Cr was taken as a measure of cell death. M. arginini induced only low levels of cytotoxicity or none at all. Both arthritogenic and non-arthritogenic strains of M. arthritidis induced the cytotoxic response. The degree of cytotoxicity produced was directly related to the size of the initial inoculum. The presence or absence of serum in the culture medium did not contribute significantly to the cytotoxicity response.
Mycoplasmas are capable of causing arthritis in a wide variety of animal species, thus providing models for the study of both acute and chronic inflammation. Rats develop an acute suppurative arthritis after intravenous injection of Mycoplasma arthritidis (17, 33) . Although cartilage and bone damage is seen with ankylosis, the disease resolves after 50 to 60 days and viable mycoplasmas can no longer be isolated from the tissues. The animals, which develop high levels of complement-fixing antibody, become completely immune to reinfection despite the absence of metabolic inhibiting and opsonizing antibodies, which usually contribute to host defense mechanisms (8, 12) .
Of particular interest is the ability of M. arthritidis to produce a polyarthritis of mice that progresses to a more chronic phase characterized histologically by massive synovial villus hyperplasia with mononuclear and plasma cell infiltration, fibroplasia, increased vascularity, and cartilage and bone destruction (15) . Viable mycoplasmas could be recovered from some arthritic joints 217 days postinoculation (15) . Other studies have indicated that the arthritis can persist for the life of the animal (unpublished results). Both Swiss and CBA mice produced substantial levels of persisting circulating complement-fixing antibody after injection with M. arthritidis. Persisting metabolic inhibiting antibodies were detected in CBA mice (10), but only a low transient response was seen in Swiss mice (14) . These observations may relate to the greater susceptibility of Swiss mice to M. arthritidis. Although the mechanisms of the inflammatory response are not known, a cell-mediated immune reaction has been detected in mice at all stages of the disease process. A correlation between severity of arthritis and the humoral or cell-mediated immune responses of individual mice has not been found. A correlation was seen in that mycoplasmas were recovered more frequently from those animals that exhibited the most severe arthritis (10). However, cell-mediated immune phenomena are believed to play a role in the pathogenesis of respiratory lesions induced by both M. pulmonis (19; G. H. Cassel and J. R. McGhee, Abstr. Annu. Meet. Am. Soc. Microbiol. 1976, D65, p.62) and M. pneumoniae (20, 31) .
Studies were thus initiated to provide more information on the role of cell-mediated immune phenomena in the inflammatory reactions induced in mice by M. arthritidis. The present report describes and documents the unexpected finding that M. arthritidis and M. hominis in-duce normal, unsensitized lymphocytes to exert cytotoxic effects in vitro on allogeneic and syngeneic mouse fibroblast target cells.
MATERIALS AND METHODS
Mycoplasma strains and mycoplasma culture procedures. The sources of M. arthritidis 158plOp9, 14124plO iv, PG-6, PN, Campo, and Sandoz L-4 were previously described (15, 16, 22) . M. arthritidis strain 20-P, reportedly isolated from a patient with rheumatoid arthritis (24) , was supplied by E. Jansson (University of Tampere, Finland). M. arthritidis M715-011-084 (NIH), M. hominis 711-002-084 (NIH), and M. arginini 732-001-084 (NIH) were obtained from the National Institutes of Health, Bethesda, Md., courtesy of M. F. Barile. Each organism was grown in modified Hayflick medium consisting of PPLO broth or agar (Difco Laboratories, Detroit, Mich.) supplemented with final concentrations of 15% (vol/vol) inactivated horse serum, 5% (vol/vol) fresh yeast extract, and 1,000 U of penicillin G per ml (6, 23) . Broth cultures were harvested in the log phase of growth 3 to 5 days postinoculation. The cultures were divided into 1-to 2-ml portions and frozen to -70°C until used. Random tubes of frozen cultures were thawed and titered by preparing serial 10-fold dilutions in mycoplasma broth and plating 0.01 ml in triplicate on mycoplasma agar. After 3 to 5 days of growth on agar, the colony-forming unit (CFU) titer per milliliter was determined by averaging the number of colonies in the highest dilution showing 10 to 50 colonies per 0.01 ml and multiplying by the dilution factor and by 100. For experimental use, the organisms were rapidly thawed at 37°C and diluted in the appropriate tissue culture medium.
Target (29) .
As illustrated in Fig. 2 ever, these weaker reactions were insufficient to interfere with the later cytotoxicity studies.
Effect of viable mycoplasmas on lymphocytes. A factor that might contribute to increased 5"Cr release from target cells is the possible death and dissolution of lymphocytes induced by viable mycoplasmas. The resulting spillage of intracellular contents from lymphocytes might be toxic to target cells. Measurement of the survival of normal CBA lymphocytes in the presence and absence of viable M. arthritidis 158plOp9 revealed that the mycoplasmas did not exert any cytotoxic effects on the lymphocytes for the 5-day duration of the experiments. Viable mycoplasmas were not only nontoxic, but appeared to enhance the survival rate of the lymphocytes (Fig. 4) . Thus, after 3 days, the survival rate decreased rapidly, whereas viable mycoplasmas somehow stabilized the lymphocyte survival rate. Whether this phenomenon is mediated by a pH balance or by a mycoplasma component promoting replication of the lymphocytes is not known at this time.
Mycoplasma enhancement of cytotoxicity with allogeneic L-cells as targets. When normal CBA lymphocytes and 51Cr-labeled Lcells were incubated together in the absence of mycoplasmas, there was a significant progressive rise in 5"Cr release, indicating target cell death. Thus, after 48 h, 18.8% 51Cr release was observed.
Since this is an allogeneic system, it would be expected that histocompatibility antigens would cause increasing lymphocyte-mediated cytotoxicity. However, the addition of mycoplasmas at a 1:1 ratio with lymphocytes caused a significant increase in the amount of 5"Cr released (Fig. 5 , Table 1 ). M. hominis and all strains of M. arthritidis tested showed this effect dramatically (5"Cr release values ranged from 51.2 to 63.7% at 48 h), whereas M. arginini induced a weaker, but still significant, response (31.3% release at 48 h). Interestingly, at the 6-h test time, none of the mycoplasmas tested, except M. arthritidis Sandoz L-4, showed significant differences from controls (viable mycoplasmas). At all subsequent sampling times, each mycoplasma elicited a significant cytotoxicity response.
Mycoplasma enhancement of cytotoxicity with CBA-MEF as targets. In contrast to the allogeneic system, the addition of normal CBA lymphocytes to 51Cr-labeled CBA-MEF resulted in no significant killing of cells (Fig. 6 M. arthritidis 14124plO iv was also used to determine the effect of increased initial inoculum on the degree of cytotoxicity induced by lymphocytes toward CBA-MEF. Mycoplasma inocula of 104, 106, and 108 CFU per well were tested. The results are summarized in Fig. 7 . The cytotoxicity reaction was found to be dose dependent at sample times beyond 6 h. At 18, 24, and 48 h, a statistically significant difference existed between 108 and 104 CFU of M. arthritidis. At 18 and 24 h, but not at 48 h, there was a statistically significant difference between the 106-and 104-CFU inocula in inducing cytotoxicity. However, only at 48 h was the difference in cytotoxicity between 108 and 106 CFU statistically significant (P < 0.05). Even though some of the differences are not statistically significant, the trend of increasing cytotoxicity with increasing numbers of mycoplasmas is readily apparent from the graph. At no time period during the assay was there any cytotoxicity produced in the absence of lymphocytes. Thus, even an inoculum size of 108 CFU per well had no effect on 61Cr release from target cells (data not shown).
Effect of fetal calf serum on cytotoxicity.
Because horse serum can stimulate lymphocytes in a syngeneic cytotoxicity assay (32) , it was of interest to determine whether fetal calf serum affected mycoplasma-induced cytotoxicity with 51Cr-labeled CBA-MEF as targets. RPMI medium with 10% inactivated fetal calf serum and RPMI alone were compared in the presence and absence of M. arthritidis 14124plO iv for their ability to promote a cytotoxic reaction. The presence or absence of serum made little difference in the amount of cytotoxicity produced in the presence or absence of M. arthritidis 14124plO iv (Fig. 8) . In fact, the presence of serum appeared to slightly depress the cytotoxic effect when compared with serum-free medium, as evidenced by the 51Cr release values of 34.7 and 43%, respectively, at 48 h. DISCUSSION The present study has shown that viable M. arthritidis and M. hominis are capable of inducing normal mouse lymphocytes to exert cytotoxic effects on both allogeneic and syngeneic MEF. As reviewed by Stanbridge (30) , mycoplasmas are capable of interacting with animal cells in a variety of ways, but in most cases the arginine-utilizing species have been reported to inhibit lymphocyte functions, including antibody synthesis, both in vitro and in vivo (2, 3, 5, 18, 25, 28) . However, despite these observations, inhibition of lymphocyte functions has not always been found. Thus, whereas Cole et al. ' Mycoplasmas and lymphocytes were added at time 0. Percentage is the mean ± one standard deviation of all the individual animals tested. Statistical analysis compared each experimental group, containing mycoplasmas, to the control group, without mycoplasmas; any P value > 0.05 was considered insignificant. exhibit a decreased response to phytohemagglutinin or bacterial lipopolysaccharide. In addition, the persisting high levels of complement-fixing antibody after a single injection of organisms were not consistent with an immunosuppressive response. Furthermore, it has also been shown that viable M. arthritidis is capable of inducing interferon in vivo after injection into mice (27) and in vitro when added to sheep or human lymphocyte cultures (11) . More recently, M. pulmonis (9, 21) and M. pneumoniae (4) (glucose utilizers) have been reported to be mitogenic for normal lymphocytes, and additional studies in our laboratories suggest that a wide range of species exhibit this property (7).
The cytotoxic reactions described in the present communication occurred consistently with the M. arthritidis strains tested, which are indigenous to rats, and M. hominis, which is indigenous to humans. Neither of these species infects mice naturally, and all of the mice used in these studies were isolated from our laboratories to avoid cross-infection before sacrifice. Concomitant work by us, using normal untreated CBA mice from the same supplier, has consistently failed to demonstrate evidence of a specific humoral or cell-mediated immune response against M. arthritidis, although experimentally infected mice exhibited such reactions (10; unpublished results). The ability of various strains of M. arthritidis to induce cytotoxicity in vitro appears not to be related to their pathogenicity in vivo. Thus, M. arthritidis 158plOp9 and 14124plO iv readily produce arthritis in mice after intravenous injection, whereas similar doses of strain PG-6 were non-arthritogenic (22) . In addition, M. hominis, a human species that has not been isolated from rodents, induced a similar cytotoxic reaction. It should be realized that the mechanisms of inflammation and the mechanisms of virulence or tissue invasion may not be the same. Differences in the reaction of the host to virulent and avirulent strains of M. arthritidis have been detected. The avirulent M. arthritidis strain H606 is eliminated from the peripheral circulation of mice and rats more rapidly than is the virulent strain 158plOp9 (13) . In addition, avirulent M. arthritidis strains appear to be more susceptible to the cidal properties of immune serum than are virulent strains (22) . Therefore, properties that circumvent host defense mechanisms may determine virulence, whereas a shared property of many mycoplasmas (such as induction of cytotoxicity) may be involved in the actual inflammatory response.
The significance of our studies on M. arthritidis-induced lymphocytotoxicity in vitro is that they point to a possible inflammatory mechanism in vivo. Thus, the activation of normal lymphocytes in vivo could provide a mechanism for cell damage early in the course of infection. Persisting viable mycoplasmas would ensure a continuing inflammatory response enhanced by the later development of a specific cell-mediated immunity. The mechanisms by which normal lymphocytes become activated in the presence of mycoplasmas is further defined in the accompanying papers (1, 7) .
